Q/C Technologies, Inc. Current Income Tax Expense (Benefit)
Q/C Technologies, Inc. (QCLS) reported Current Income Tax Expense (Benefit) of $895.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-04-11.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2017-04-11
- Q/C Technologies, Inc. current income tax expense (benefit) for fiscal 2016 was $895.00K, a 72.28% decline from fiscal 2015.
- Q/C Technologies, Inc. current income tax expense (benefit) for fiscal 2015 was $3.23M, a 149.14% increase from fiscal 2014.
- Q/C Technologies, Inc. current income tax expense (benefit) for fiscal 2014 was $1.30M, a 76.00% increase from fiscal 2013.
- Q/C Technologies, Inc. current income tax expense (benefit) for fiscal 2013 was $736.33K.
| Period end | Current Income Tax Expense (Benefit) 12 month | Current Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2016-12-31 | $895.00K 10-K · filed 2017-04-11 | |
| 2015-12-31 | $3.23M 10-K · filed 2017-04-11 | $269.34K 10-K · filed 2016-03-30 |
| 2014-12-31 | $1.30M 10-K · filed 2016-03-30 | |
| 2013-12-31 | $736.33K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |